Pharmaceutical News

RSS

Novel compound stops brain cell degeneration in Alzheimer's disease

Drug discovery researchers at Northwestern University have developed a novel orally administered compound specifically targeted to suppress brain cell inflammation and neuron loss associated with Alzheimer's disease.

22 Jan 2006

Black box warnings for two eczema creams

Food and Drug Administration officials in the U.S. have announced that two prescription creams to treat eczema will now carry strong warnings about the possible risk of skin cancer, lymphoma and other cancers.

22 Jan 2006

Danger of resistance to malaria drug

The World Health Organization (WHO) has issued new guidelines concerning the use of the malaria drug Artemisinin.

22 Jan 2006

Argentina and Brazil join forces to produce AIDS drugs

Argentina's Health Ministry has announced that in partnership with the Brazilian government they plan to produce their own anti-AIDS drugs in an effort to lower the cost of treatment.

19 Jan 2006

FDA unpopular over label liability revamp

The Food and Drug Administration in the U.S. has said that federally approved drug labels pre-empt state liability laws and are part of a revamp of the lengthy, hard-to-read instructions that come with medicines.

19 Jan 2006

Galapagos and Cancer Research Technology announce new anti-cancer drug discovery collaboration

Galapagos NV and Cancer Research Technology ("CRT"), specialists in oncology drug discovery and commercialization, a wholly owned company of Cancer Research UK, announced today that they have entered into a new collaboration in anti-cancer drug discovery research.

19 Jan 2006

Caretek Medical signs feasibility agreement with major pharma for protein based drug

Caretek Medical Ltd, an Oxford-based company developing an innovative needle-free drug delivery system, today announced that it has signed a feasibility study agreement with a major global pharmaceutical company.

19 Jan 2006

Vioxx may still be the best option for treating some forms of arthritis

Scientists believe that despite the current concerns around anti-inflammatory drugs like Vioxx, they may still be the best option for treating some forms of arthritis.

18 Jan 2006

Hopes dashed for peanut allergy drug Xolair

Hopes have been dashed for a potential treatment for peanut allergies following the severe reactions suffered by two children during a clinical trial.

18 Jan 2006

Anti-Obesity diet drug from cannabis works!

For those whose New Year's resolution was to yet again try to lose those extra kilos help may be at hand in the form of a new wonder drug derived from cannabis.

17 Jan 2006

FDA warns against buying prescription drugs on the net or overseas

According to the U.S. Food and Drug Administration (FDA), consumers and healthcare professionals who fill out their prescriptions abroad are putting themselves at risk.

17 Jan 2006

Drug discovery companies turn to low-cost Asian countries to evade stringent regulations

The Indian and Chinese drug discovery outsourcing market is riding a crest with companies from outside Asia increasingly seeking to outsource drug discovery to these countries for greater cost savings. Other major factors driving this shift to Indian and Chinese companies are the better access to expertise, productivity gains, process improvements, variable costs, avoidance of capital outlays and opportunities for companies to focus on specific niches.

16 Jan 2006

US warns older flu drugs often don't work

Health authorities in the U.S. are advising doctors to stop using two drugs to treat this winters influenza because it has become evident that the most common strain has become resistant to the drugs and they are unlikely to work.

16 Jan 2006

FDA warns diet drugs contain Prozac and Librium

The FDA has issued a warning to consumers that diet pills from Brazil have been found to contain active drug ingredients which are possibly harmful.

16 Jan 2006

European Medicines Agency receives first pandemic influenza vaccine application

The European Medicines Agency has received the first application for a pandemic influenza vaccine, submitted by GlaxoSmithKline Biologicals.

10 Jan 2006

Approval of first immune globulin for use beneath the skin

The U.S. Food and Drug Administration (FDA) has announced the approval of the first immune globulin product for subcutaneous injection for the prevention of serious infections in patients with Primary Immune Deficiency Diseases (PIDD).

10 Jan 2006

Human Genome Sciences announces license agreement with Amgen

Human Genome Sciences has announced a license agreement with Amgen under which Amgen has acquired exclusive worldwide rights to develop and commercialize therapeutic biological products for human use based on a human gene discovered by Human Genome Sciences that may have potential applications in autoimmune diseases, immune deficiencies or suppression, and cancer.

10 Jan 2006

Non-prescription cough medicine won't help that cough

According to a panel of experts in the U.S. cough medicines bought over the counter do little good and may in fact harm children.

9 Jan 2006

Thalomid gives hope for blood cancer sufferers

Drug company Celgene says it has halted a pivotal-stage trial of its Thalomid drug earlier than expected after the drug was shown to dramatically limit the progress of the blood cancer multiple myeloma.

9 Jan 2006

Data establishes safety profile of new GlaxoSmithKline rotavirus vaccine candidate

Data from one of the largest infant vaccine trials ever conducted, published in the New England Journal of Medicine (NEJM), showed GlaxoSmithKline's (GSK) rotavirus vaccine candidate as effective against rotavirus disease (rotavirus gastroenteritis) in the first year of life. Rotavirus is the leading recognized cause of diarrhea-related illness and death among infants and young children.

6 Jan 2006